peoplePerson
Matthew Meyerson
Co-discovered EGFR mutations in lung cancer and linked Fusobacterium to colorectal cancer.
Genomicist whose lab co-reported EGFR mutations (2004), mapped lung adenocarcinoma genomes for TCGA, and identified Fusobacterium nucleatum enrichment in colorectal tumours.
Role
Director, Center for Cancer Genomics, Dana-Farber; Institute Member, Broad
Institution
Specialisms
Lung cancer genomicsEGFR mutationsMicrobiome and cancer
| Title | Journal | Year |
|---|---|---|
| EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Science | 2004 |
| Genomic analysis identifies association of Fusobacterium with colorectal carcinoma | Genome Research | 2012 |
Pages like this
not linked directly; found by shared links- TrialLAURA
Shares EGFR, Non-small-cell lung cancer.
- ProductDacomitinib
Shares EGFR, Non-small-cell lung cancer.
- PersonDaniel A. Haber
Shares EGFR, Non-small-cell lung cancer.
- PersonThomas J. Lynch Jr.
Shares EGFR, Non-small-cell lung cancer.
- InstitutionAichi Cancer Center
Shares EGFR, Colorectal cancer, Non-small-cell lung cancer.
- PersonJean-Charles Soria
Shares EGFR, Non-small-cell lung cancer.
- PersonLecia V. Sequist
Shares EGFR, Non-small-cell lung cancer.
- InstitutionVanderbilt-Ingram Cancer Center
Shares EGFR, Colorectal cancer, Non-small-cell lung cancer.